Clinical Trial

A Study of Radical Cystectomy in Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) and Muscle Invasive Bladder Cancer (MIBC) in Korea

Study acronym: BC RC DB
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assess participant's overall well-being and the extent to which medical services are used by participants with non-muscle invasive bladder cancer (NMIBC) and muscle invasive bladder cancer (MIBC) who have undergone radical cystectomy (surgical procedure to remove entire urinary bladder). NMIBC is a type of bladder cancer in which cancer is confined to innermost lining of the bladder and MIBC is a type of bladder cancer in which cancer has grown deep into the thick muscle of the bladder.
Trial Details
NCT Number NCT07735793
Lead Sponsor Janssen Korea, Ltd., Korea
Conditions Urinary Bladder Neoplasms
Enrollment 1 participants
Start Date 2026-07-27
Primary Completion 2026-11-23 (estimated)
Study Completion 2026-11-23 (estimated)
Updated on ClinicalTrials.gov 2026-07-30